QID 377972

Date Published: 2023-06-08

QID 377972: Trend Micro Apex One (On-Prem) Multiple Vulnerabilities (000290464)

Trend Micro Apex One protection offers advanced automated threat detection and response against an ever-growing variety of threats, including file-less and ransomware.

CVE-2022-24678: Trend Micro Apex One Security Agent Resource Exhaustion Denial-of-Service Vulnerability
CVE-2022-24679: Trend Micro Apex One Security Agent Link Following Local Privilege Escalation Vulnerability.

CVE-2022-24680: Trend Micro Apex One Security Agent Link Following Local Privilege Escalation Vulnerability.

Note: An attacker must first obtain the ability to execute low-privileged code on the target system in order to exploit this vulnerability.

Affected Versions:
Trend Micro Apex One 2019 (On-Prem) prior to build 10071

QID Detection Logic:(Authenticated):
This QID checks for vulnerable version of Trend Micro Apex by fetching the version from registry

Successful exploitation of the vulnerability may allow a local attacker to escalate privileges on and modify files.

  • CVSS V3 rated as High - 7.8 severity.
  • CVSS V2 rated as High - 7.2 severity.
    • Solution
    Vendor has released patch addressing the vulnerabilities, for more information please refer to Trend Micro Security Advisory

    Vendor References

    CVEs related to QID 377972

    CVE-2022-24678 | CVE-2022-24679 | CVE-2022-24680 |
    Software Advisories
    Advisory ID Software Component Link
    000290464 URL Logo success.trendmicro.com/dcx/s/solution/000290464?language=en_US
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].